FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy

Clin Nucl Med. 1999 Apr;24(4):261-3. doi: 10.1097/00003072-199904000-00009.

Abstract

Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Neoplasms / diagnostic imaging
  • Abdominal Neoplasms / secondary*
  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary*
  • Adult
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Colectomy
  • Colonic Neoplasms / drug therapy*
  • Fluorodeoxyglucose F18*
  • Fluorouracil / administration & dosage
  • Follow-Up Studies
  • Humans
  • Lymphatic Metastasis / diagnostic imaging*
  • Male
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Remission Induction
  • Tomography, X-Ray Computed*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Fluorouracil
  • Camptothecin